Slab Contrasted Wiso 4 is a very bold, very wide, medium contrast, upright, normal x-height font visually similar to 'Polyphonic' by Monotype (names referenced only for comparison).
Keywords: headlines, posters, sports branding, packaging, signage, assertive, retro, collegiate, industrial, playful, high impact, retro signage, brand presence, durability, slab serif, bracketed serifs, blocky, compact counters, soft corners.
A heavy, wide slab-serif with squared, bracketed terminals and a distinctly blocky silhouette. The strokes are robust with moderate contrast, and the counters are compact, creating dense, high-impact word shapes. Serifs read as thick rectangular slabs with softened joins, giving the letterforms a sturdy, carved-in feel rather than razor-sharp geometry. Numerals and lowercase maintain the same chunky rhythm, with rounded bowls and short, strong arms that keep spacing visually tight at display sizes.
Best suited to display typography such as headlines, posters, and prominent labels where its chunky slabs and wide proportions can read clearly. It also fits sports- and campus-inspired branding, event graphics, packaging, and signage systems that benefit from a bold, durable voice.
The overall tone is confident and attention-grabbing, with a vintage, collegiate energy that also nods to old industrial signage and print ephemera. Its weight and width make it feel emphatic and sturdy, while the rounded internal shapes keep it approachable rather than severe.
The design appears intended to deliver maximum impact with a classic slab-serif structure—pairing thick, bracketed serifs with wide proportions for strong, recognizable word shapes. Its softened joins and rounded bowls suggest a goal of combining ruggedness with a friendly, retro readability.
At smaller sizes the dense counters and strong slabs can darken quickly, so it visually prefers generous tracking and display-scale settings. The design’s pronounced horizontals and wide stance help it hold presence in short headlines, badges, and logotype-style treatments.